S. Day

420 total citations
12 papers, 247 citations indexed

About

S. Day is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, S. Day has authored 12 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in S. Day's work include Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (4 papers) and BRCA gene mutations in cancer (3 papers). S. Day is often cited by papers focused on Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (4 papers) and BRCA gene mutations in cancer (3 papers). S. Day collaborates with scholars based in United States. S. Day's co-authors include Therese B. Bevers, J E Lennard‐Jones, Geoffrey K. Turnbull, D G Thompson, J. Cambil Martín, E. R. C. Walker, Behrang Amini, Najat C. Daw, Jasmina Bojadzieva and Louise C. Strong and has published in prestigious journals such as Gut, Familial Cancer and Breast Diseases A Year Book Quarterly.

In The Last Decade

S. Day

11 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Day United States 5 105 101 51 39 39 12 247
Tshela E. Mason United States 10 50 0.5× 148 1.5× 38 0.7× 37 0.9× 10 0.3× 20 324
W. Holtkamp Germany 8 54 0.5× 89 0.9× 51 1.0× 25 0.6× 7 0.2× 24 261
Ferhunde Dizdaroğlu Türkiye 11 29 0.3× 90 0.9× 64 1.3× 18 0.5× 23 0.6× 18 309
Rafael Cabrera Portugal 10 36 0.3× 61 0.6× 72 1.4× 41 1.1× 17 0.4× 26 310
Henrik Csaba Horváth Hungary 10 105 1.0× 52 0.5× 62 1.2× 40 1.0× 6 0.2× 20 316
C Wolff Chile 12 84 0.8× 65 0.6× 56 1.1× 20 0.5× 5 0.1× 26 355
Evangelos Chandanos Sweden 7 90 0.9× 108 1.1× 18 0.4× 30 0.8× 28 0.7× 9 364
Kazutoshi Mizunashi Japan 9 46 0.4× 64 0.6× 38 0.7× 23 0.6× 117 3.0× 24 390
Nicola Bradshaw United Kingdom 6 55 0.5× 195 1.9× 43 0.8× 112 2.9× 10 0.3× 8 356
Yushan Lisa Wilson United States 6 74 0.7× 42 0.4× 111 2.2× 15 0.4× 6 0.2× 7 304

Countries citing papers authored by S. Day

Since Specialization
Citations

This map shows the geographic impact of S. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Day more than expected).

Fields of papers citing papers by S. Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Day. The network helps show where S. Day may publish in the future.

Co-authorship network of co-authors of S. Day

This figure shows the co-authorship network connecting the top 25 collaborators of S. Day. A scholar is included among the top collaborators of S. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Day. S. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Day, S. & Therese B. Bevers. (2016). Breast Cancer Risk by Extent and Type of Atypical Hyperplasia: An Update From the Nurses' Health Studies. Breast Diseases A Year Book Quarterly. 27(4). 264–265. 4 indexed citations
3.
Day, S. & Therese B. Bevers. (2016). Risk-Benefit Profiles of Women Using Tamoxifen for Chemoprevention. Breast Diseases A Year Book Quarterly. 27(1). 31–33.
4.
Day, S., et al.. (2015). Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer. Breast Diseases A Year Book Quarterly. 26(2). 123–124. 2 indexed citations
5.
Day, S. & Therese B. Bevers. (2013). Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. Breast Diseases A Year Book Quarterly. 24(4). 324–326. 9 indexed citations
6.
Day, S. & Therese B. Bevers. (2012). Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials. Breast Diseases A Year Book Quarterly. 23(3). 227–228. 3 indexed citations
7.
Day, S. & Therese B. Bevers. (2012). Cost-Effectiveness of Chemoprevention of Breast Cancer Using Tamoxifen in a Postmenopausal US Population. Breast Diseases A Year Book Quarterly. 23(2). 195–196. 2 indexed citations
8.
Day, S. & Therese B. Bevers. (2011). Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy. Breast Diseases A Year Book Quarterly. 22(4). 360–362. 120 indexed citations
9.
Day, S. & Therese B. Bevers. (2011). Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women. Breast Diseases A Year Book Quarterly. 22(2). 178–180. 6 indexed citations
10.
Day, S. & Therese B. Bevers. (2010). Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial. Breast Diseases A Year Book Quarterly. 21(1). 79–81. 2 indexed citations
11.
Day, S. & Therese B. Bevers. (2009). Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997. Breast Diseases A Year Book Quarterly. 20(4). 381–382. 2 indexed citations
12.
Turnbull, Geoffrey K., D G Thompson, S. Day, et al.. (1989). Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women.. Gut. 30(1). 30–34. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026